ER
Emma Reeve (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in PTC Therapeutics, Inc. (PTCT). The largest single filing was $795K of PTCT (10,000 sh × $79.50, as filed), executed Nov 21 2025. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 21 2025
Filed Nov 25 2025
Median ADV $125.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
PTCTRecent filings
PTCTSALE
PTC Therapeutics, Inc.
View filing →
$795K10,000 sh × $79.50
Exec Nov 21 2025
Filed Nov 25 2025 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. View filing → $546K
7,333 sh × $74.50
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. View filing → $1.1M
15,666 sh across 2 lots
Exec Oct 30 2025
Filed Oct 31 2025 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. View filing → $1.7M
25,562 sh across 9 lots
Exec Oct 3 2025
Filed Oct 7 2025 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. View filing → $805K
13,534 sh across 2 lots
Exec Sep 11 2025
Filed Sep 16 2025 · 5:30 PM ET †